Cancer researchers have been buzzing for a couple years about immunotherapy. Many studies are pointing the way to combinations of drugs that complement each other at the molecular level, and ought to work better than single cancer therapies alone.

from Forbes – Tech http://ift.tt/2cyrhDQ
via IFTTT